-
Dior nods to Hollywood's Golden Age with Cruise collection
-
Fifth straight IPL loss for Punjab as Varma slams 75 for Mumbai
-
Better late than never, Higgo fires 69 after PGA penalty
-
Australia's Kerr to leave Chelsea Women at season's end
-
US tariffs, cyberattack drive Jaguar Land Rover into loss
-
Austrian feminist artist Valie Export dies aged 85
-
Russia pummels Kyiv, killing at least 10 and denting peace hopes
-
Israelis chant threats, anti-Palestinian slogans at Jerusalem Day march
-
New 'Godfather' novel to tell mafia story from women's perspective
-
South African Potgieter grabs early PGA clubhouse lead
-
NY's Met museum to take over Neue Galerie
-
US senators vote to withhold own pay in government shutdowns
-
Ballerini pounces for Giro win as sprint favourites crash
-
IMF sees risks to global growth forecast over sustained Iran war
-
China's Weichai wins battle for Ferretti yacht maker
-
Japan's Mitoma a major doubt for World Cup
-
Elliott's lack of action at Villa has been embarrassing: Emery
-
Princess Catherine wraps up Italy visit with pasta class
-
Sinner breaks Masters 1000 winning streak record at Italian Open, Gauff in final
-
Honda suspends plans for new electric vehicle plant in Canada
-
Sniffer dogs police Cannes' cocaine-fuelled party scene
-
McFarlane calls on Chelsea to save troubled season with FA Cup glory
-
Lebanon, Israel hold new talks in US as ceasefire nears end
-
Spain gears up for August total solar eclipse
-
Tech stocks rally rolls on as US-China talks underway
-
Russia pummels Kyiv, killing seven and denting peace hopes
-
Xi's 'blunt' warning to Trump on Taiwan exposes profound risks: analysts
-
Blackouts and protests as Cuba says fuel has 'run out'
-
Germany's Jaeger takes early PGA lead as McIlroy opens with bogey
-
Sinner reaches Italian Open semis, breaks Masters 1000 winning streak record
-
Germany's Merz calls for more investment, less subsidies in EU budget
-
UK minister quits ahead of possible challenge to Starmer
-
Latvia prime minister resigns over straying Ukraine drones
-
Stocks diverge tracking tech, US-China talks
-
Afghanistan's water crisis worsened last year: UN report
-
Russia pummels Kyiv, killing five and denting peace hopes
-
Stars flying into Cannes in private jets 'obscene', say ex-pilots
-
McIlroy eyeing early charge as PGA Championship begins
-
Arteta seeks goal spree for Premier League title cushion
-
UK PM in peril as potential successors jockey for position
-
US jury awards $49.5 mn damages to Boeing 737 MAX victim's family
-
South Africa court clears way for Zuma's arms graft trial
-
Nobel winner Mukwege warns of predatory US deal for DR Congo
-
UK economy resilient as Mideast war, political risks loom
-
Russia pummels Kyiv, killing three and denting peace hopes
-
Subdued Trump left waiting for 'big hug' from Xi
-
Slot has 'every reason to believe' he will remain as Liverpool boss
-
British PM battles to stay in power amid rebellion
-
Ex-Philippine drug war enforcer flees Senate refuge
-
U2 surprise fans in Mexico City to shoot music video
Who should get paid for nature's sequenced genes?
Much of the vanilla that flavors our ice cream today is artificial, derived from the genetic signature of a plant that hundreds of years ago was known only to an Indigenous Mexican tribe.
The plant's sequenced genomic information, available on public databases, was used as the basis for a synthetic flavoring that today competes with vanilla grown in several countries, mainly by small-scale farmers.
Few, if any, benefits of the lucrative scientific advance have trickled down to the communities that gave us vanilla in the first place.
"Wild genetic resources and pharmaceuticals ... are a multi-multi-billion dollar businesses. They clearly are profitable... that's not in dispute," Charles Barber of the World Resources Institute think tank told AFP.
"A great deal of really valuable information has fed into the system from research and utilization of wild genetic resources. And there is no mechanism currently to compensate the people where this information is coming from" in the form of digitally sequenced data, he added.
Much of the information comes from poor countries.
Fair sharing of the gains derived from digitally-stored genetic sequencing data has been a headache for negotiators at the COP16 biodiversity summit into its second week in Cali, Colombia.
At the last conference, in Montreal in 2022, 196 country parties to the UN's Convention on Biological Diversity (CBD) agreed to create a benefit-sharing mechanism for the use of digital sequence information (DSI).
Two years later, they still need to resolve such basic questions as who pays, how much, into which fund, and to whom does the money go?
- 'Cheap and very fast' -
The issue is a complex one.
There is little debate that genetic data-sharing on mostly free-access platforms is crucial for human advancement through medicine and vaccine development, for example.
But how to quantify the value of the sequenced information itself? And should the first people to discover a plant's particular usefulness be compensated?
"Sequencing technology has become so advanced that you can go with a... handheld device a little bit bigger than a cell phone and you can literally sequence a genome in an hour or two and upload it as you sequence it," Pierre du Plessis, a DSI expert and former negotiator for African countries at the CBD told AFP.
These gene sequences are then uploaded to databases which artificial intelligence can mine for potential leads for product development.
DSI is worth an estimated hundreds of billions of dollars a year. And there is a lot of it out there.
"Once the sequence is put into a public database, generally, no benefit-sharing obligations apply," Nithin Ramakrishnan, a researcher with the Third World Network, an advocacy NGO for developing countries, told AFP in Cali.
"Like when the sandalwood sequence information is available in the database whether India wants to share its sandalwood... with a cosmetic company or not, doesn't matter.
- Mandatory -
A point of contention in Cali is a demand from developing countries that payment for DSI use be mandatory, perhaps through a one-percent levy on profits from drugs, cosmetics or other products.
They also want guarantees of non-monetary benefits such as access to vaccines produced from genetic information sequenced from viruses and other pathogens.
"We want real understanding, sector-specific understanding of what non-monetary benefits will be shared and we want the system to be obligatory -- the users should have some form of obligation to share benefits," said Ramakrishnan.
Another sticking point is access for Indigenous people and local communities to DSI funds.
Developing countries want the information on genetic databases to be traceable and "answerable to governments" of the countries where it comes from, said Ramakrishnan.
But rich nations and many researchers oppose such a model which they fear will be too onerous, potentially putting the brakes on scientific pursuits that could benefit all humankind.
With such divergent points of view, observers are doubtful the Cali COP will emerge with any firm decisions on the outstanding questions by closing time on Friday.
The World Wildlife Fund has said "many more rounds of negotiations appear necessary" on DSI.
Added Barber: "I think it's not going to all get solved here."
I.Meyer--BTB